IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$7.38
Tradestie Score
55
Market Cap
$1.09B
Revenue Growth
0.9%
Analyst Upside
+133.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.24
|
$1.18B | - | 62 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.24
|
$1.17B | - | 65 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.74
|
$1.15B | 4.9 | 47 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$12.49
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$12.96
|
$1.14B | - | 43 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$30.81
|
$1.13B | - | 32 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.20
|
$1.12B | - | 47 | Compare |
|
NKTR
Nektar Therapeutics
|
$37.00
|
$1.12B | - | 62 | Compare |
More IMTX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry